20-20 Investing is an application to help individuals that invest in pharmaceutical and biotechnology companies to better understand the $500 billion prescription drug market.
Over 150 public drug companies that sell and/or develop over 1,000 prescription drugs that treat over 300 medical conditions are covered in detail within the application.
The easy to use navigational features allow the user to easily track and search what companies make what drugs for what medical conditions.
The free version includes the home page dashboard with stock price % changes for different time periods, upcoming events and links to company stock, drug and financial reports.
The in-app purchase for $4.99/yr will allow the user to gain access to full lists of all covered companies, drugs, medical conditions, quarterly drug revenue and competing drug comparisons.
20-20 Investing is updated daily with the most recent stock price performance, financial results and regulatory changes.
Have 20-20 Investing be your vision into pharmaceutical and biotech investments.